Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis,BJU International

当前位置： X-MOL 学术 › BJU Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis
BJU International ( IF 4.5 ) Pub Date : 2021-11-25 , DOI: 10.1111/bju.15653
Juan Victor Ariel Franco ₁ , Jae Hung Jung _{2,

3} , Mari Imamura ₄ , Michael Borofsky ₅ , Muhammad Imran Omar _{6,

7} , Camila Micaela Escobar Liquitay ₈ , Shamar Young ₉ , Jafar Golzarian ₉ , Areti Angeliki Veroniki ₁₀ , Luis Garegnani ₁ , Philipp Dahm ₁₁

Affiliation

Associate Cochrane Centre, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Department of Urology, Yonsei University Wonju College of Medicine, Wonju, South Korea.
Center of Evidence-Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, South Korea.
Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Department of Urology, University of Minnesota, Minneapolis, MN, USA.
Guidelines Office, European Association of Urology, Arnhem, The Netherlands.
Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
Central Library, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Department of Radiology, Division of Interventional Radiology & Vascular Imaging, University of Minnesota, Minneapolis, MN, USA.
Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Urology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.

To assess the comparative effectiveness and ranking of minimally invasive treatments (MITs) for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).

中文翻译：